General Information of the Compound
Compound ID
CP0018970
Compound Name
3-[[4-(1-methylpyrazol-4-yl)phenyl]methyl]-2H-indazole-5-carboxamide
    Show/Hide
Structure
Formula
C19H17N5O
Molecular Weight
331.379
Canonical SMILES
Cn1cc(cn1)-c1ccc(Cc2n[nH]c3ccc(cc23)C(N)=O)cc1
    Show/Hide
InChI
InChI=1S/C19H17N5O/c1-24-11-15(10-21-24)13-4-2-12(3-5-13)8-18-16-9-14(19(20)25)6-7-17(16)22-23-18/h2-7,9-11H,8H2,1H3,(H2,20,25)(H,22,23)
    Show/Hide
InChIKey
LCUMHIHAYAXPDL-UHFFFAOYSA-N
Physicochemical Property
logP
2.6531
Rotatable Bonds
4
Heavy Atom Count
25
Polar Areas
89.59
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
4
Complexity
25

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 118959844
ChEMBL ID
CHEMBL3775614
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01975, Cyclin-dependent kinase 8
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 270 nM
   TI
   LI
   LO
   TS